Professional Documents
Culture Documents
Upper Airway Obstruction: Critical Care Pearls
Upper Airway Obstruction: Critical Care Pearls
37
389
Palatine tonsil
Tongue
Oral pharynx
Retropharyngeal space
Root of tongue
Geniohyoid muscle
Mylohyoid muscle
Submandibular
space
Vallecula
Epiglottis
Hypophyarynx
Vocal cord
Thyroid cartilage
Larynx
Cricoid cartilage
Trachea
Sternum
Figure 37-1 Anatomy of the upper airway. (Adapted from Aboussouan L, Stoller JK. Diagnosis
and management of upper airway obstruction. Clin Chest Med. 1994;15:35-53; with permission.)
390
Systemic Disorders
mouth) can be associated with severe soft tissue swelling causing UAO.
The differential diagnosis of UAO is wide
and varies by age group and by clinical setting. Table 37-1 summarizes the most common causes of airway obstruction. Figures
37-2 and 37-3 show examples of benign and
malignant causes of UAO.
Investigations
The most important diagnostic tool if UAO is
suspected is a quick history and physical
examination. Many times, management of a
patient with UAO must start simultaneously
with the diagnostic process. It is useful to
separate patients with potential UAO into
those with severe symptoms and impending
respiratory failure and those with a more
indolent course and less severe symptoms. It
is important to understand that airway resistance varies inversely with the fourth power of
the radius at the point of UAO, and that small
changes in the underlying pathology may
dramatically worsen respiratory airflow.
Computed Tomography
Computed tomography (CT) can be important in investigating UAO in the stable
patient or in the unstable patient with an
already secured airway. High-resolution CT
of neck and chest can help identify intrinsic
and extrinsic tumors, vascular structures,
and foreign bodies. It can also provide information on the degree and extension of airway
compromise in UAO (1,4). However, the risks
and benefits of transporting such a patient to
391
Spirometry
Spirometry can be used in the patient with
gradual and mild symptoms of UAO. It is relatively insensitive and has no role in the management of a patient with acute respiratory
distress (3,4). Analysis of the flow-volume
loops may be helpful suggesting the location
and functional severity of the obstruction
(Figure 37-4 A-D).
Bronchoscopy
Rigid or flexible bronchoscopy with direct
visualization is the most effective tool in
establishing diagnosis and frequently provides the best way to correct UAO. The rigid
bronchoscope can be used in the emergency
setting to secure the airway by carefully passing it through the stenotic segment.
Flexible bronchoscopy can be used to establish the diagnosis as well deliver treatment
including laser therapy, photoresection, electrocautery electrosurgery, balloon bronchoplasty,
and tracheal stenting once the airway has been
secured and the patient stabilized (2,3). It is
important to have a secured airway or the
immediate means to have one because flexible
bronchoscopy can worsen UAO to a critical level.
Management
Establishing a secure and patent airway is the
most important goal in the resuscitation of a
patient with acute UAO. A quick evaluation
considering age group, history, physical
examination, and clinical circumstances helps
determine the site and cause of obstruction,
the severity of the obstruction, and the need
to establish an airway urgently.
In the outpatient setting the most common
cause of UAO is obstruction of the larynx with
a foreign body. Heimlich maneuver is recommended for relief of the airway obstruction in
adults and children one to eight years of age. A
392
Systemic Disorders
10
10
Expiration
Airflow, L/ S
Airflow, L/ S
Expiration
Inspiration
10
10
100
Inspiration
Lung volume, % VC
10
100
Lung volume, % VC
10
Expiration
5
Airflow, L/ S
Airflow, L/ S
Expiration
Inspiration
Inspiration
10
10
100
Lung volume, % VC
100
Lung volume, % VC
Figure 37-4 Flow-volume curves in upper airway obstruction. (A) indicates the normal contour of
the inspiratory and expiratory curves; (B) With variable intrathoracic obstruction (e.g.,
tracheomalacia within the thorax), obstruction is marked during exhalation with marked truncation
of the expiratory curve; (C) With variable extrathoracic obstruction (e.g., collapse of tracheal cartilage in the neck following trauma), obstruction is more marked during inspiration; (D) Finally, with
fixed obstructions (e.g., tracheal stenosis), both the inspiratory and expiratory curves are markedly
truncated. (Adapted from Hall JB, Schmidt GA, Wood LD, eds. Principles of Critical Care. New York:
McGraw-Hill; 1992; with permission.)
Racemic Epinephrine
Racemic epinephrine is usually used in circumstances when the patient with a partial
UAO is still conscious and able to ventilate,
and vasoconstriction is desired to decrease
mucosal edema.
Racemic epinephrine administered by
means of a nebulizer has been proven to be
effective in treating croup (laryngotracheobronchitis) in the pediatric population
decreasing morbidity, mortality, and hospital
stay (6). Conversely, racemic epinephrine is
not effective in the treatment of epiglottitis
and may be deleterious (7).
Racemic epinephrine also is used to treat
postextubation laryngeal edema, which has
been reported to occur from 2.3% to 6.9% (8).
The typical case is that of a patient, breathing
easily for the first two or three hours, followed
by the gradual progression of dyspnea,
inspiratory stridor, and increased work of
breathing. In this situation repeat racemic
epinephrine treatments can be used as a temporary measure until the acute swelling and
inflammation subsides. These patients should
remain in the intensive care unit under careful observation until it is confirmed that the
UAO has resolved or greatly improved.
Corticosteroids
Corticosteroids have been used to treat UAO
because of their potential beneficial effect in
393
Heliox
Heliox, a heliumoxygen gas mixture, is
effective in reducing the work of breathing by
decreasing airway resistance to turbulent
flow in the density-dependent pressure drop
across the airway obstruction. Heliox has
been used in several conditions including
postextubation laryngeal edema, tracheal
stenosis or extrinsic compression, status
asthmaticus, and angioedema (11,12).
To be effective, the heliumoxygen ratio
must be at least 70:30. Unfortunately, most
patients with UAO also have lung disease with
varying degrees of hypoxemia preventing the
use of heliox at effective concentrations.
Although the work of breathing and dyspnea
improves to some degree with the use of
heliox, the mechanical obstruction is still in
place. The use of heliox in patients with
severe UAO should only be used to provide
temporary support pending definitive diagnosis and management.
Endotracheal Intubation
In most cases of UAO, the patency of the
upper airway can be reestablished with endotracheal intubation after rapid assessment of
the patients airway anatomy. Evaluation of
394
Systemic Disorders
Surgical Interventions
Laser Therapy
Tracheal Stenting
Tracheal stents placed using either rigid or
flexible bronchoscopy can be helpful to maintain a patent airway in patients with tracheal
obstruction caused by benign or malignant
conditions. Airway resection and reconstruction provide the definitive correction, but
Complications
Pulmonary Edema
Postobstructive pulmonary edema is the sudden onset of edema following UAO without
evidence of any other underlying cardiopul-
395
Summary
Upper airway obstruction is a potentially fatal
emergency faced by critical care physicians. It
can be caused by myriad conditions that will
require a particular treatment after appropriate diagnosis. Regardless of the specific cause,
the patient with UAO must be carefully monitored in the ICU for impending respiratory
failure. A secure and patent airway should be
established if clinical deterioration is seen.
Pharmacologic interventions have limited
396
Systemic Disorders
Stridor suggestive of
UAO
Urgent establishment of
patent airway
Is ET intubation
possible?
Yes
Direct or fiberoptic
intubation
No
Crycothyroidotomy vs
Tracheotomy
Figure 37-5 Algorithm for management of upper airway obstruction. (CT = computed tomography;
ET = endotracheal; UAO = upper airway obstruction.)
REFERENCES
1. Jacobson S. Upper airway obstruction. Emerg
Med Clin North Am. 1989;7:205-17.
2. Khosh MM, Lebovics RS. Upper airway obstruction. In: Parrillo JE, Dellinger RP, eds. Critical
Care Medecine. St. Louis: Mosby; 2001:808-25.
3. King EG, Sheehan GJ, McDonell TJ. Upper airway obstruction. In: Hall JB, Schmidt GA,
Wood LD, eds. Principles of Critical Care. New
York: McGraw-Hill; 1992:1710-8.
4. Aboussouan L, Stoller JK. Diagnosis and management of upper airway obstruction. Clin
Chest Med. 94119;5:35-53.
5. Dickison AE. The normal and abnormal pediatric airway. Recognition and management of
obstruction. Clin Chest Med. 87819;5:83-96.
6. Quan L. Diagnosis and treatment of croup. Am
Fam Physician. 92419;6:747-55.
7. Kissoon N, Mitchell I. Adverse effects of
racemic epinephrine in epiglottitis. Pediatr
Emerg Care. 85119;143-4.
8. Darmon JY, Rauss A, Dreyffus D, et al. Evaluation
of risk factors for laryngeal edema after tracheal
extubation in adults and its prevention by dexamethasone. Anesthesiology. 1992;77:245-51.
9. Kairys SW, Olmstead EM, OConnor GT.
Steroid treatment of laryngotracheitis: a metaanalysis of the evidence from randomized trials. Pediatrics. 1989;83:683-93.
10. McCulloch TM, Bishop MJ. Complications of
translaryngeal intubation. Clin Chest Med.
1991;12:507-21.
11. Boorstein JM, Boorstein SM, Humphries GN,
et al. Using heliumoxygen mixtures in the
emergency management of acute upper airway
obstruction. Ann Emerg Med. 1989;18:688-90.
12. Curtis JL, Mahlmeister M, Fink JB, et al.
Heliumoxygen gas therapy. Chest. 1986;90:
455-7.
13. Feller-Kopman D. Acute complications of artificial airways. Clin Chest Med. 2003;24:445-55.
14. Steinert R, Lullwitz E. Failed intubation with
case reports. HNO. 1987;35:439-42.
15. Goldberg J, Levy PS, Morkovin V, Goldberg JB.
Mortality from traumatic injuries: a casecontrol study using data from the national
hospital discharge survey. Med Care. 1983;21:
692-704.
16. Wood DE, Liu YH, Vallieres E, et al. Airway
stenting for malignant and benign tracheobronchial stenosis. Ann Thorac Surg. 2003;76:
167-74.
397